benitec/calimmune sydney presentation, page-13

"Calimmune is also developing a rich product candidate pipeline to address the needs of different types of individuals at different states of HIV infection and with different levels of treatment experience."

One would think they won't be curing but will be controlling this disease. I wouldn't be banking on anything from Cal-1 for a while.

Thinking that a partnership will come for the ling cancer and provide upfront monies we have ready spent, that might save the day mid year.